Cell therapy manufacturing

Robustness for every stage

In cell therapy, progress carries real urgency.

Advancing from early development toward clinical and commercial GMP manufacturing means navigating process variability, scale-up, and regulatory complexity.

To keep progress on track, we deliver solutions that support both today’s discovery and tomorrow’s demand—enabling reliable workflows and a clear path to scale.

More than cell therapy manufacturing

No matter where you are in your cell therapy workflow, we offer scientific support that removes friction at every stage of the journey and evolves with the industry.

Process development, optimization, and tech transfer

Optimize processes, navigate scale up, and de‑risk tech transfer with specialist support.

Learn more

Regulatory readiness

Prepare for your next phase with regulatory documentation, strategy, and expert guidance.

Learn more

Equipment and process training

Equip your team for GMP manufacturing with hands‑on and custom training courses.

Learn more

Your science, our solutions

We were lucky to be part of the pioneering work that turned the earliest CAR T vision into a real-life treatment ― and we haven’t stopped innovating since.

Solving today’s manufacturing challenges

Advanced tools and strategies we’re delivering to address current demands for scale, consistency, and affordability in cell therapy.

Digitalization and automation
Single-use technology
Decentralized manufacturing

Developing tomorrow’s manufacturing models

Emerging approaches our teams are developing to help redefine complex disease treatment and patient care.

Robotic platforms
Allogeneic, off-the-shelf therapies
HSC gene editing via lipid nanoparticles

Strategies that turn efficiency into throughput

Increase productivity through automated, small‑footprint workflows designed for parallel processing.

Cell therapy development, accelerated

Thoughtfully designed to help you overcome the biggest hurdles in cell therapy manufacturing.

E-book

Modular systems

Scale from R&D to commercialization with modular workflows that adapt as demand grows and processes evolve.

Blog

End-to-end digitalization

Enable process standardization with digital workflows and batch records that support control, traceability, and regulatory readiness.

Blog

Closed and automated platforms

Improve process reliability and productivity while reducing the risk of contamination and batch failure.

Get the most from your cell therapy manufacturing process

Find out how our process development specialists  can address key pain points.

View infographic

Get the most from your cell therapy manufacturing process

Connect with our cell therapy team

Whether you’re shaping your first protocol or preparing for GMP scale, we’re here to help.

Ask a question. Outline a challenge. Or simply start a conversation. We’ll connect you with someone who understands your workflow and what it takes to advance it.

Frequently asked questions about cell therapy workflows

What are the main stages of a cell therapy workflow?

Most workflows include collection, isolation, activation, genetic modification, expansion, harvest, formulation, QC testing, and cryopreservation.

What’s the difference between autologous and allogeneic cell therapy workflows?

Autologous workflows use cells from the patient and require strict identity control; allogeneic workflows focus on scaling consistent donor‑derived batches.

Why is cell isolation such an important step?

Isolation quality affects activation, expansion, potency, and final product consistency.

How does closed‑system technology improve workflows?

Closed systems reduce contamination risk, support reproducibility, and simplify regulatory compliance.

What are key QC tests in the workflow?

Common tests include identity, viability, sterility, mycoplasma, endotoxin, potency, and genetic modification confirmation.

Why is cryopreservation important?

Cryopreservation stabilizes cell products for storage and transport while protecting viability and function.

Shop in your local currency and language

Powering your cell therapy progress

Manufacturing solutions and expertise to reduce variability, accelerate clinical progress, and de-risk scale-up across autologous and allogeneic therapies.

Robustness for every stage

More than cell therapy manufacturing

Process development, optimization, and tech transfer

Regulatory readiness

Equipment and process training

Your science, our solutions

Solving today’s manufacturing challenges

Developing tomorrow’s manufacturing models

Strategies that turn efficiency into throughput

Cell therapy development, accelerated

Modular systems

End-to-end digitalization

Closed and automated platforms

Get the most from your cell therapy manufacturing process

Connect with our cell therapy team

Frequently asked questions about cell therapy workflows

What are the main stages of a cell therapy workflow?

What’s the difference between autologous and allogeneic cell therapy workflows?

Why is cell isolation such an important step?

How does closed‑system technology improve workflows?

What are key QC tests in the workflow?

Why is cryopreservation important?

Did you find what you were looking for?